Dexamethasone Sodium Phosphate Injection, Solution
Product Images NDC 55150-237

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Dexamethasone Sodium Phosphate (NDC 55150-237). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (4 mg per mL Container Label)

Label for Dexamethasone Sodium Phosphate Injection USP, 4 mg per mL, in a 1 mL single-dose vial. The label indicates use for intravenous or intramuscular administration, includes storage instructions at 20° to 25°C, and notes the product contains preservatives. Manufactured by AuroMedics Pharma LLC for Eugia US LLC.*

FDA Label Image

Package Label-principal Display Panel (4 mg per mL Container-Carton (25 Vials))

Packaging label for Dexamethasone Sodium Phosphate Injection USP 4 mg per mL, an injectable solution for intravenous, intramuscular, intra-articular, soft tissue, or intralesional use. The carton indicates 25 single-dose vials of 1 mL each. Labeler is Auromedics with distribution by AuroMedics Pharma LLC, E. Windsor, NJ. The label includes storage instructions and ingredient details.*

FDA Label Image

Package Label-principal Display Panel (20 mg per 5 mL (4 mg / mL) Container Label)

Label for Dexamethasone Sodium Phosphate Injection USP, 4 mg/mL (20 mg per 5 mL) in a 5 mL multiple-dose vial. The label includes usage indications for intravenous or intramuscular routes, storage instructions, preservative warning, and manufacturing information by AuroMedics Pharma LLC, E. Windsor, NJ.*

FDA Label Image

Package Label-principal Display Panel (20 mg per 5 mL (4 mg / mL) Container-Carton (25 Vials))

Packaging label for Dexamethasone Sodium Phosphate Injection USP 20 mg per 5 mL (4 mg/mL) multiple-dose vials. The label shows the product name, strength, dosage form, sterile status, and routes of administration including intravenous, intramuscular, intra-articular, soft tissue, and intralesional use. The labeler appears as Auromedics Pharma LLC with distribution details, barcode, NDC 55150-238-05, storage instructions, and manufacturing information.*

FDA Label Image

Package Label-principal Display Panel (120 mg per 30 mL (4 mg / mL) Container Label)

Label for Dexamethasone Sodium Phosphate Injection USP, 4 mg/mL (120 mg per 30 mL) solution in a multiple-dose vial. Intended for intravenous, intramuscular, intra-articular, soft tissue, or intralesional use. Distributed by AuroMedics Pharma LLC, made in India. Includes storage instructions and formulation details.*

FDA Label Image

Package Label-principal Display Panel (120 mg per 30 mL (4 mg / mL) Container-Carton (25 Vials))

Packaging label for Dexamethasone Sodium Phosphate Injection USP 120 mg per 30 mL (4 mg/mL), solution for injection. The label indicates multiple routes of administration: intravenous, intramuscular, intra-articular, soft tissue, or intralesional use. It is distributed by AuroMedics Pharma LLC and includes storage and composition information. The package contains 25 multiple-dose vials of 30 mL each.*

FDA Label Image

Dexamethasone Sodium Phosphate Chemical Structure (Dexamethasone Str)

Chemical structure diagram of dexamethasone sodium phosphate, showing its steroid backbone and phosphate group attachment as part of the molecule.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.